TARRYTOWN, N.Y., Dec. 19, 2017 /PRNewswire/ — Araim Pharmaceuticals Inc., a biotechnology company with a platform of innate repair receptor (IRR) activating compounds, today announced the publication of preclinical research performed at the University of Messina, Italy, demonstrating the…
